Rare Disease Therapeutics Market- Global Industry Size, Share, Trends, Competition, Opportunity and Forecast, 2018-2028

Segmented By Therapeutic Area (Cancer, Cardiovascular Disorders, Musculoskeletal Disorders, Hematologic Disorders, Infectious Diseases, Metabolic Disorders, Endocrine Disorders, Others), By Route of Administration (Oral, Injectable, Others), By Drug Type (Biologics, Biosimilars, Small Molecule), By Distribution Channel (Hospital Pharmacies, Specialty Pharmacies, Online Pharmacies), By Region and Competition

Published	Pages	Publisher	Report code
Mar 2023	113	TechSci Research	ASDR-618448

Published: Mar 2023 - Pages : 113 - Publisher : TechSci Research - Report code : ASDR-618448

1.Novartis AG
2.Pfizer Inc.
3.F Hoffmann-La Roche Ltd.
4.AbbVie Inc
5.Novo Nordisk A/S
6.Sanofi SA
7.Bayer AG
8.Amgen Inc
9.Eisai Co Ltd
10.Bristol-Myers Squibb Co

Europe Rare Disease Genetic Testing Market: Analysis and Forecast, 2023-2033

This report can be of interest as well:

Europe Rare Disease Genetic Testing Market: Analysis and Forecast, 2023-2033

Published: March, 2024 | Report code: ASDR-661422